Dr. Soliman Abdul Kader Fakeeh Hospital Co. vs Dallah Healthcare Co.
A head-to-head of Dr. Soliman Abdul Kader Fakeeh Hospital Co. (4017) and Dallah Healthcare Co. (4004) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
Dr. Soliman Abdul Kader Fakeeh Hospital Co.
4017
34.76 SAR
-1.03%
VS
Dallah Healthcare Co.
4004
106.50 SAR
-0.84%
| Metric | 4017 | 4004 |
|---|---|---|
| Market Cap | 8.01B SAR | 10.78B SAR |
| P/E (TTM) | 30.23 | 20.02 |
| Forward P/E | 21.07 | 20.80 |
| P/S | 2.59 | 2.67 |
| P/B | 2.51 | 2.64 |
| EV/EBITDA | 22.21 | 20.79 |
| Dividend Yield | — | 1.79% |
| Profit Margin | 8.77% | 11.15% |
| Gross Margin | 19.32% | 35.71% |
| Operating Margin | 6.16% | 15.40% |
| Revenue Growth (YoY) | -2.50% | +21.68% |
| FCF Yield | -2.30% | -0.21% |
| Debt / Equity | 20.66 | 94.09 |
| Current Ratio | 1.65 | 1.20 |
Which is better: Dr. Soliman Abdul Kader Fakeeh Hospital Co. or Dallah Healthcare Co.?
- ✓Larger by market cap: Dallah Healthcare Co.
- ✓Cheaper valuation (lower P/E): Dallah Healthcare Co.
- ✓More profitable (net margin): Dallah Healthcare Co.
- ✓Faster revenue growth: Dallah Healthcare Co.
- ✓Higher free-cash-flow yield: Dallah Healthcare Co.
Across 12 available metrics, Dallah Healthcare Co. leads 8–4.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
Compare Dr. Soliman Abdul Kader Fakeeh Hospital Co. with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.